<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    msa
   </journal-id>
   <journal-title-group>
    <journal-title>
     Materials Sciences and Applications
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2153-117X
   </issn>
   <issn publication-format="print">
    2153-1188
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/msa.2024.1511035
   </article-id>
   <article-id pub-id-type="publisher-id">
    msa-137438
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Chemistry 
     </subject>
     <subject>
       Materials Science
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Electrochemical Sensor for Dopamine Detection Based on the CRISPR/Cas12 System
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Liu
      </surname>
      <given-names>
       Huang
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Hongqu
      </surname>
      <given-names>
       Liang
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Binyu
      </surname>
      <given-names>
       Bi
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Weijuan
      </surname>
      <given-names>
       Yan
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Jun
      </surname>
      <given-names>
       Zhou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Xuebin
      </surname>
      <given-names>
       Li
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aDepartment of Neurology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aClinical Medicine School of Youjiang Medical University for Nationalities, Baise, China
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     18
    </day> 
    <month>
     11
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    11
   </issue>
   <fpage>
    528
   </fpage>
   <lpage>
    537
   </lpage>
   <history>
    <date date-type="received">
     <day>
      11,
     </day>
     <month>
      October
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      15,
     </day>
     <month>
      October
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      15,
     </day>
     <month>
      November
     </month>
     <year>
      2024
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    Dopamine is an important neurotransmitter and biomarker that is involved in many physiological processes in the body as well as the control of the central nervous system. Therefore, it is crucial to accurately monitor dopamine concentrations in organisms in order to comprehend their biological roles and make correct clinical diagnoses. In this work, we describe the development of an aptamer sensor utilizing gold electrodes and cyclic voltammetry. Using a self-assembly approach, a single-chain sulfhydrylated dopamine-specific aptamer was immobilized on the surface of a gold electrode to successfully create the aptamer sensor. Voltammetry was used to do a thorough electrochemical characterization in order to assess the sensor’s performance. According to the findings, the created electrochemical sensor demonstrated outstanding analytical capabilities for the detection of dopamine, including a wide linear response range, a very low detection limit, high sensitivity, and great selectivity. These characteristics make the sensor a novel approach for the quick and precise detection of dopamine, and it is anticipated that clinical diagnostics and biological research will use it extensively.
   </abstract>
   <kwd-group> 
    <kwd>
     CRISPR/Cas12
    </kwd> 
    <kwd>
      Dopamine
    </kwd> 
    <kwd>
      Electrochemical Biosensor
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Neurotransmitters are key messengers that perform a variety of functions in the nervous system. Dopamine (DA) is currently the most studied neurotransmitter due to its critical role in the human brain and nervous system, and this neurotransmitter is essential for neuronal development, attention, learning, and control of stress responses <xref ref-type="bibr" rid="scirp.137438-1">
     [1]
    </xref>. Its primary functions include the circulatory system, kidneys, hormones, central nervous system, and motivational actions <xref ref-type="bibr" rid="scirp.137438-2">
     [2]
    </xref>. Dopamine concentrations affect how the brain functions, feels, and behaves in both people and animals. A number of theories propose that diseases like schizophrenia, Parkinson’s disease, and attention deficit hyperactivity disorder are caused by anomalies in dopamine levels <xref ref-type="bibr" rid="scirp.137438-3">
     [3]
    </xref>. Damage to the neurons involved in dopamine synthesis is the root cause of many illnesses. A number of illnesses and neurological disorders, including hypertension, schizophrenia, attention deficit hyperactivity disorder, Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease, are frequently linked to abnormalities in the amounts of dopamine (DA) in biological fluids and tissues <xref ref-type="bibr" rid="scirp.137438-4">
     [4]
    </xref> <xref ref-type="bibr" rid="scirp.137438-5">
     [5]
    </xref>. Because of the low concentration levels of DA in biological samples, which are typically in the region of nM, the development of dependable, accurate, and affordable sensing methods for the detection of DA in biological samples is crucial in analytical and diagnostic applications <xref ref-type="bibr" rid="scirp.137438-6">
     [6]
    </xref> <xref ref-type="bibr" rid="scirp.137438-7">
     [7]
    </xref>.</p>
   <p>Dopamine has been detected using a variety of quantitative techniques up to this point, including spectrophotometry, high-performance liquid chromatography, and electrophoresis. These techniques might be costly and necessitate lengthy experiments <xref ref-type="bibr" rid="scirp.137438-8">
     [8]
    </xref> <xref ref-type="bibr" rid="scirp.137438-9">
     [9]
    </xref>. As a result, scientists have been working to develop more accurate and cost-effective techniques for detecting dopamine in biological fluids. Due to its affordability, ease of use, portability of the equipment, and the fact that dopamine is redox-active, electrochemical detection has been the method of choice up to this point <xref ref-type="bibr" rid="scirp.137438-10">
     [10]
    </xref>-<xref ref-type="bibr" rid="scirp.137438-12">
     [12]
    </xref>. Dopamine is less concentrated in physiological settings than other electrochemically active chemicals like uric acid and ascorbic acid, which presents a hurdle for the detection of dopamine utilizing electrochemical methods <xref ref-type="bibr" rid="scirp.137438-13">
     [13]
    </xref> <xref ref-type="bibr" rid="scirp.137438-14">
     [14]
    </xref>. Furthermore, biological samples may also contain catechol, norepinephrine, and adrenaline, among other compounds that are recognized as interfering substances due to their similar oxidation potential and competitive sensitivities, when it comes to the detection of dopamine in biological samples. For instance, it is typically discovered that ascorbic acid has hundreds to thousands of times the potency of DA <xref ref-type="bibr" rid="scirp.137438-15">
     [15]
    </xref>-<xref ref-type="bibr" rid="scirp.137438-17">
     [17]
    </xref>. Thus, it’s critical to overcome the selectivity problem in the creation of dopamine electrochemical sensors.</p>
   <p>A workable method for the selective detection of dopamine is the creation of biosensors. Low detection limits and strong selectivity are two benefits of biosensors. As a result, biosensors can lessen the difficulty posed by the previously mentioned chemical interferents. A bioreceptor that has been subjected to a biorecognition process with the intended analyte is typically necessary for biosensors. Enzymes, antibodies, DNA, RNA, and whole cells can all function as these receptors. An aptamer is a particular DNA or RNA that has been chosen to bind to a particular target in an immunosensor, such as an antibody <xref ref-type="bibr" rid="scirp.137438-18">
     [18]
    </xref>. Short, manufactured ligands with a single strand that have a high affinity and specificity for their target molecules are known as nucleic acid aptamers. These features dictate how widely aptamers are used in the development of aptamer-based biosensors, commonly referred to as aptamer sensors <xref ref-type="bibr" rid="scirp.137438-19">
     [19]
    </xref>. Low cost, small size, easy synthesis, powerful recognition ability, and high binding affinity to targets are the characteristics of aptamers <xref ref-type="bibr" rid="scirp.137438-20">
     [20]
    </xref> <xref ref-type="bibr" rid="scirp.137438-21">
     [21]
    </xref>. Since these characteristics are superior to those of conventional antibodies, they can be used to improve the efficiency and specificity of electrochemical biosensors.</p>
   <p>Because of their comparatively high reaction rate, specificity, and usage of comparatively basic and affordable equipment, electrochemical approaches have been developed. The electrochemical detection of dopamine and other neurotransmitters has been extensively studied <xref ref-type="bibr" rid="scirp.137438-22">
     [22]
    </xref>. Through, electrochemical techniques like cyclic voltammetry make it simple to identify dopamine in aqueous solutions. Aptamers have been studied by a number of research organizations as potential recognition components for dopamine sensors. 58 Nucleotide aptamers can bind to gold electrodes, and dopamine aptamers can electrostatically adsorb onto aminothiol-modified gold surfaces to create colorimetric dopamine sensors. The aptamer-dopamine binding process encourages the aggregation of the gold nanoparticles, which in turn causes the color change of the neurotransmitters. In order to complete the electrochemical sensor construction, cDNA and 6-mercapto-1-hexanol (6-MCH) were sequentially loaded onto the electrode. The sensor construction process was then applied to characterize and detect the sensor by applying cyclic voltammetry (CV) and by the amplitude of the anode and cathode currents of the electrodes. The CRISPR/Cas12a system detects dopamine using a specific group (ferrocene), which is labeled with ferrocene (Fc) into cDNA. The anodic and cathodic current amplitudes were utilized to calculate the dopamine concentration.</p>
  </sec><sec id="s2">
   <title>2. Experimental Design and Methodology</title>
   <sec id="s2_1">
    <title>2.1. Materials and Equipment</title>
    <p>The single-stranded DNA sulfhydrylated aptamer probe sequence was ACGTTTTATCTGCCCCAGTGTTCTC-(CH2)-6-SH, Apt single-stranded as Fc-GTCTCTGTGTGTGCGCCAGAGAGAACACTGGGGCAGATATGGGGCCAGCACAGAATGAGGCCC, and the nucleic acid sequence was purchased from Shanghai Sangong Bioengineering Technology Co. DA, MgCl<sub>2</sub>, KCl, NaOH, NaCl, and potassium ferricyanide was purchased from Shanghai Aladdin Biochemical Technology Co. Tris-HCl was purchased from Amresco. 0.3 µm, 0.05 µm Al<sub>2</sub>O<sub>3</sub> was purchased from Shanghai Chenhua Instrument Co. The working rod gold electrode (Au), auxiliary platinum wire electrode (Pt), and reference electrode were Ag/AgCl. The electrochemical workstation (CHI660e) was used to perform cyclic voltammetry (CV) curves in 0.5 mm [Fe(CN)<sub>6</sub>]<sup>3</sup><sup>−</sup><sup>/4</sup><sup>−</sup>. 0.5 mM [Fe(CN)<sub>6</sub>]<sup>3</sup><sup>−</sup><sup>/4</sup><sup>−</sup> was configured with PBS solution. Ultrasonic oscillator (JYD-250) and water-bath constant temperature oscillator (SHA-C).</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Preparation of Gold Electrodes</title>
    <p>Bare gold electrodes were immersed in a tigerfish solution containing 30% H<sub>2</sub>O<sub>2</sub> and 70% concentrated H<sub>2</sub>SO<sub>4</sub> for 1 hour. The main objective was to completely remove the oxide layer and thus regenerate the surface of the gold electrode. After completing the treatment, the electrode was then thoroughly rinsed with a thorough rinse of deionized water to ensure that a flawless, oxide-free surface was obtained. Next, the surface of the gold electrodes was refined, starting with 0.3 µm and 0.05 µm aluminum oxide powder (Al<sub>2</sub>O<sub>3</sub>), with a precise polishing process lasting about 30 min to obtain a properly smooth surface. Subsequently, residual Al<sub>2</sub>O<sub>3</sub> powder is removed by an ultrasonic cleaning process. This thorough cleaning procedure consisted of successive washes with deionized water, ethanol, and deionized water, each lasting 5 min, to ensure complete removal of all impurities. Upon completion of the cleaning procedure, the cleaned gold electrodes were subjected to another thorough washing with deionized water, followed by drying using nitrogen gas. Finally, the electrode was immersed in cDNA solution for 10 h to allow the cDNA to be completely modified on the electrode surface by Au-S bonding.</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. Preparation for DA Solution</title>
    <p>10 × PBS was diluted 10-fold with deionized water to obtain 1 × PBS, which was used as a buffer. 0.038 g of DA was added to 100 mL of 1 × PBS to prepare a 20 μM DA solution, and the 20 μM DA solution was diluted with 1 × PBS in an appropriate ratio to obtain a lower concentration of DA solution.</p>
   </sec>
   <sec id="s2_4">
    <title>2.4. Electrochemical Determination of DA</title>
    <p>
     <xref ref-type="bibr" rid="scirp.137438-"></xref>A bare gold electrode was used as the working electrode. Ag/AgCl and Pt electrodes were used as reference and auxiliary electrodes, respectively. The electrochemical behavior of different concentrations of DA on the modified electrode was analyzed using CV. The CV curves were recorded for 30 cycles using an electrochemical workstation (CHI660e) scanned in the voltage range of −0.2 - 0.4 V at a scan rate of 100 mV s.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results and Discussion</title>
   <sec id="s3_1">
    <title>3.1. DA electrochemical Biosensor Principle</title>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>Figure 1. DA electrochemical biosensor principle.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/7703028-rId12.jpeg?20241119022628" />
    </fig>
    <p>
     <xref ref-type="bibr" rid="scirp.137438-"></xref></p>
    <p>As shown in <xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>, the cDNA was first loaded on the bare gold electrode, which was subsequently filled with 6-MCH, and the S-Au bond ensured the stability of the cDNA binding to the gold electrode, and finally the Fc-labeled dopamine Apt strand was bound to the cDNA, at which time the electrochemical signal was maintained at a higher level due to the presence of the Fc electrochemical signaling molecule on the electrode. When DA is contained in the solution to be measured, DA binds to Apt, resulting in a subsequent Fc-Apt movement away from the electrode, leading to a decrease in the electrochemical signal, thus realizing the detection of DA.</p>
   </sec>
   <sec id="s3_2">
    <title>3.2. Electrochemical Characterization of DA Biosensors</title>
    <p>The electrochemical behavior of the gold electrode was observed using electrochemical methods in potassium ferricyanide solution; the more loadings on the electrode, the lower the redox peak. We used CV to characterize the biosensor build change process. From <xref ref-type="fig" rid="fig2">
      Figure 2
     </xref>, it can be seen that the bare gold electrode has the largest redox peak (curve a), followed by a gradual decrease in the current of the redox peak when the cDNA signaling probe (curve b) and 6-MCH (curve c) are sequentially modified on the electrode, the electrode transfer of electrons is blocked. After continuing to load on Fc-Apt (curve d), the redox peak value continued to decrease, and when DA solution was added, Fc-Apt reacted with DA (curve e), Fc-Apt moved away from the electrode, and the redox peak value increased. This indicates that the electrochemical sensor was successfully constructed.</p>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.137438-"></xref>Figure 2. a curve represents bare gold electrode, b curve represents cDNA loaded on gold electrode, c curve represents 6-MCH loaded on electrode, d curve represents loaded Fc-Apt, and e curve represents Fc-Apt after reaction with DA.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/7703028-rId13.jpeg?20241119022629" />
    </fig>
   </sec>
   <sec id="s3_3">
    <title>3.3. Optimization of Experimental Conditions</title>
    <p>We carefully considered our options when choosing the experimental setup to ensure the electrochemical sensor operated at its peak efficiency. Included in this are the ideal DA concentration and reaction time. Since the concentration of the DA solution and the reaction time of the Apt chain with the DA solution are important, we set up various DA solution concentrations and calculate the time of the solution’s steady state as well as the ideal reaction concentration at steady state in order to determine the ideal reaction concentration and reaction time.</p>
    <p>As shown in <xref ref-type="fig" rid="fig3(A)">
      Figure 3(A)
     </xref>, the current tends to stabilize when the reaction time reaches 10 min, and the current is stable at 15 min, so the optimal time for the solution to react to a steady state is 15 min. Configure different concentrations of DA solution 5 μM, 10 μM, 15 μM, 20 μM, 25 μM, respectively, take the optimal reaction time of 15 min, and measure the electrochemical signals, as shown in <xref ref-type="fig" rid="fig3(B)">
      Figure 3(B)
     </xref>, the concentration of 5 μM, 10 μM, 15 μM, 20 μM, 25 μM, in that order, the 5 μM electrochemical signal response value is the largest, so we set the optimal response concentration as 5 μM.</p>
    <fig id="fig3" position="float">
     <label>Figure 3</label>
     <caption>
      <title>Figure 3. Optimization of experimental conditions. (A) Currents for DA solution reaction times. (B) Currents for reactions with different DA solution concentrations.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/7703028-rId14.jpeg?20241119022629" />
    </fig>
   </sec>
   <sec id="s3_4">
    <title>3.4. DA Electrochemical Biosensor Platform Performance</title>
    <p>The biosensor platform was used to measure different concentrations of DA solutions and analyze their electrochemical signal values to evaluate the sensitivity of the developed electrochemical biosensing platform to detect them. <xref ref-type="fig" rid="fig4(A)">
      Figure 4(A)
     </xref>, <xref ref-type="fig" rid="fig4(B)">
      Figure 4(B)
     </xref> shows how different concentrations of DA solutions affect the responsiveness of electrochemical signals.</p>
    <p>The initial DA concentration in this experiment was 5 μM/L. As the DA solution concentration continued to increase, the electrochemical signal was linearly related to the logarithm of the DA solution concentration (lgC, with C representing the DA solution concentration), and in this study, a linear regression equation was established, which showed that there was a linear relationship between the level of the electrochemical signal and the concentration of the DA solution, with Y = −1.45 × 10<sup>−</sup><sup>9</sup> LgC + 3.91 × 10<sup>−</sup><sup>7</sup>, R<sup>2</sup> = 0.993, and the limit of detection was determined to be 4.67 μmol/L according to the general equation LOD = 3σ/k, where k is the slope of the linear regression equation and σ is the standard deviation. Therefore, this biosensor is highly sensitive to the detection of the target target, which suggests that our constructed electrochemical biosensor can be used to detect DA.</p>
    <fig id="fig4" position="float">
     <label>Figure 4</label>
     <caption>
      <title>Figure 4. (A - B) Electrochemical signals of different concentrations of DA solutions after sensor treatment.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/7703028-rId15.jpeg?20241119022629" />
    </fig>
    <fig id="fig5" position="float">
     <label>Figure 5</label>
     <caption>
      <title>Figure 5. (A - B) Specificity of DA electrochemical biosensors.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/7703028-rId16.jpeg?20241119022629" />
    </fig>
   </sec>
   <sec id="s3_5">
    <title>3.5. Specificity of DA Electrochemical Biosensors</title>
    <p>We chose various approaches for the measurement of sensor specificity in order to confirm, under ideal experimental conditions, that the biosensor is specific for the detection of DA. This study was divided into five groups: potassium chloride (KCL), dopamine solution (DA), uric acid solution (UA), 5% glucose solution (GLU), and blank control group (Blank). <xref ref-type="fig" rid="fig5">
      Figure 5
     </xref> illustrates this: while the sensor responds to the electrochemical signals of the Glu, UA, and blank control group in some way, there is almost no difference, indicating that the sensor lacks specificity for any of these groups. In addition, the electrochemical signals of the DA group are much lower than those of other groups, which indicates that the experimental method has good selectivity for DA solution. This is enough to prove that the electrochemical sensor platform we developed has obvious specificity for the detection of DA solutions.</p>
   </sec>
   <sec id="s3_6">
    <title>3.6. Determination of the Recovery of DA Solution</title>
    <p>We simulated the samples in a serum environment, diluted GLU, UA, and KCL with PBS solution, and added various doses of DA to assess the recoveries in order to test the method’s applicability. <xref ref-type="table" rid="table1">
      Table 1
     </xref> displays the method’s recoveries, which ranged from 83.93% to 96.26%. These results suggest that the electrochemical biosensor we created is useful for DA detection.</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.137438-"></xref>Table 1. DA sample recovery.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="40.93%"><p style="text-align:center">DA solution concentration (μM/L)</p></td> 
       <td class="custom-bottom-td acenter" width="34.51%"><p style="text-align:center">Average value (μM/L)</p></td> 
       <td class="custom-bottom-td acenter" width="24.56%"><p style="text-align:center">Recovery rate</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="40.93%"><p style="text-align:center">1</p></td> 
       <td class="custom-top-td acenter" width="34.51%"><p style="text-align:center">0.8393</p></td> 
       <td class="custom-top-td acenter" width="24.56%"><p style="text-align:center">83.93%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="40.93%"><p style="text-align:center">5</p></td> 
       <td class="acenter" width="34.51%"><p style="text-align:center">4.4563</p></td> 
       <td class="acenter" width="24.56%"><p style="text-align:center">89.13%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="40.93%"><p style="text-align:center">10</p></td> 
       <td class="acenter" width="34.51%"><p style="text-align:center">9.6256</p></td> 
       <td class="acenter" width="24.56%"><p style="text-align:center">96.26%</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
  </sec><sec id="s4">
   <title>4. Conclusion</title>
   <p>As part of our ongoing effort to innovate scientific research, we have effectively created a novel approach to dopamine (DA) detection using the CRISPR/Cas12 gene editing technology. This method achieves quick and sensitive detection of DA by deftly combining gene editing and nucleic acid aptamer technologies, particularly by taking advantage of the high specificity of the CRISPR/Cas12a system. Our method maintains great specificity while drastically cutting detection time when compared to current detection techniques. With a low detection limit of 4.67 μmol/L, our assay shows significant promise for real-world uses. We intend to use this technique in upcoming research to identify human serum samples, which will strongly assist clinical diagnosis. We think that this method’s excellent sample recovery and high stability would greatly increase the effectiveness of DA detection, providing patients with neurodegenerative disorders like Parkinson’s disease with speedier and more precise treatment alternatives. Furthermore, our approach is very appropriate for usage in a clinical context due to its fast assay time and ease of operation. We believe this approach will offer a new tool for the early detection and treatment of Parkinson’s disease, enhancing patients’ quality of life with additional research and optimization.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.137438-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Matt, S.M. (2020) Where Is Dopamine and how do Immune Cells See it: Dopamine-Mediated Immune Cell Function in Health and Disease. Journal of Neuroimmune Pharmacology, 15, 114-164.
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Meng, L., Wang, M., Gao, Y., Chen, L., Wang, K., Gao, W., et al. (2023) Dopamine D1 Receptor Agonist Alleviates Acute Lung Injury via Modulating Inflammatory Responses in Macrophages and Barrier Function in Airway Epithelial Cells. Free Radical Biology and Medicine, 202, 2-16. &gt;https://doi.org/10.1016/j.freeradbiomed.2023.03.016 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lai, H., Zhang, B., Shen, T., Pu, J., Jiang, Y., Yue, Y., et al. (2023) Impact of Cognition-Related Single Nucleotide Polymorphisms on Brain Imaging Phenotype in Parkinson’s Disease. Neural Regeneration Research, 18, 1154-1160. &gt;https://doi.org/10.4103/1673-5374.355764 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Porter, E., Roussakis, A., Lao-Kaim, N.P. and Piccini, P. (2020) Multimodal Dopamine Transporter (DAT) Imaging and Magnetic Resonance Imaging (MRI) to Characterise Early Parkinson’s Disease. Parkinsonism&amp;Related Disorders, 79, 26-33. &gt;https://doi.org/10.1016/j.parkreldis.2020.08.010 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Martorana, A., Di Lorenzo, F., Esposito, Z., Lo Giudice, T., Bernardi, G., Caltagirone, C., et al. (2013) Dopamine D2-Agonist Rotigotine Effects on Cortical Excitability and Central Cholinergic Transmission in Alzheimer's Disease Patients. Neuropharmacology, 64, 108-113. &gt;https://doi.org/10.1016/j.neuropharm.2012.07.015 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cernat, A., Ştefan, G., Tertis, M., Cristea, C. and Simon, I. (2020) An Overview of the Detection of Serotonin and Dopamine with Graphene-Based Sensors. Bioelectrochemistry, 136, Article 107620. &gt;https://doi.org/10.1016/j.bioelechem.2020.107620 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rusheen, A.E., Gee, T.A., Jang, D.P., Blaha, C.D., Bennet, K.E., Lee, K.H., et al. (2020) Evaluation of Electrochemical Methods for Tonic Dopamine Detection in Vivo. TRAC Trends in Analytical Chemistry, 132, Article 116049. &gt;https://doi.org/10.1016/j.trac.2020.116049 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tang, J., Jiang, S., Liu, Y., Zheng, S., Bai, L., Guo, J., et al. (2018) Electrochemical Determination of Dopamine and Uric Acid Using a Glassy Carbon Electrode Modified with a Composite Consisting of a Co (II)-Based Metalorganic Framework (ZIF-67) and Graphene Oxide. Microchimica Acta, 185, Article No. 486. &gt;https://doi.org/10.1007/s00604-018-3025-x 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kamal Eddin, F.B. and Wing Fen, Y. (2020) Recent Advances in Electrochemical and Optical Sensing of Dopamine. Sensors, 20, Article 1039. &gt;https://doi.org/10.3390/s20041039 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shimna, T., Thomas, J., Thomas, T. and Thomas, N. (2020) Porous Co
     <sub>3</sub>O
     <sub>4</sub> Modified Carbon Paste Electrode for the Quantification of Dopamine. Journal of Applied Electrochemistry, 50, 1165-1173. &gt;https://doi.org/10.1007/s10800-020-01472-7 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lu, Z., Li, Y., Liu, T., Wang, G., Sun, M., Jiang, Y., et al. (2020) A Dual-Template Imprinted Polymer Electrochemical Sensor Based on AuNPs and Nitrogen-Doped Graphene Oxide Quantum Dots Coated on NiS
     <sub>2</sub>/biomass Carbon for Simultaneous Determination of Dopamine and Chlorpromazine. Chemical Engineering Journal, 389, Article 124417. &gt;https://doi.org/10.1016/j.cej.2020.124417 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Taheri, R.A., Eskandari, K. and Negahdary, M. (2018) An Electrochemical Dopamine Aptasensor Using the Modified Au Electrode with Spindle-Shaped Gold Nanostructure. Microchemical Journal, 143, 243-251. &gt;https://doi.org/10.1016/j.microc.2018.08.008 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Selvolini, G., Lazzarini, C. and Marrazza, G. (2019) Electrochemical Nanocomposite Single-Use Sensor for Dopamine Detection. Sensors, 19, Article 3097. &gt;https://doi.org/10.3390/s19143097 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sajid, M., Nazal, M.K., Mansha, M., Alsharaa, A., Jillani, S.M.S. and Basheer, C. (2016) Chemically Modified Electrodes for Electrochemical Detection of Dopamine in the Presence of Uric Acid and Ascorbic Acid: A Review. TRAC Trends in Analytical Chemistry, 76, 15-29. &gt;https://doi.org/10.1016/j.trac.2015.09.006 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chen, Y., Li, X., Cai, G., Li, M. and Tang, D. (2021) In Situ Formation of (001) TiO
     <sub>2</sub>/Ti
     <sub>3</sub>C
     <sub>2</sub> Heterojunctions for Enhanced Photoelectrochemical Detection of Dopamine. Electrochemistry Communications, 125, Article 106987. &gt;https://doi.org/10.1016/j.elecom.2021.106987 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ezhil Vilian, A.T., Rajkumar, M. and Chen, S. (2014) In Situ Electrochemical Synthesis of Highly Loaded Zirconium Nanoparticles Decorated Reduced Graphene Oxide for the Selective Determination of Dopamine and Paracetamol in Presence of Ascorbic Acid. Colloids and Surfaces B: Biointerfaces, 115, 295-301. &gt;https://doi.org/10.1016/j.colsurfb.2013.12.014 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Patella, B., Sortino, A., Mazzara, F., Aiello, G., Drago, G., Torino, C., et al. (2021) Electrochemical Detection of Dopamine with Negligible Interference from Ascorbic and Uric Acid by Means of Reduced Graphene Oxide and Metals-NPs Based Electrodes. Analytica Chimica Acta, 1187, Article 339124. &gt;https://doi.org/10.1016/j.aca.2021.339124 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Li, Y., Zeng, R., Wang, W., Xu, J., Gong, H., Li, L., et al. (2022) Size-Controlled Engineering Photoelectrochemical Biosensor for Human Papillomavirus-16 Based on Crispr-Cas12a-Induced Disassembly of Z-Scheme Heterojunctions. ACS Sensors, 7, 1593-1601. &gt;https://doi.org/10.1021/acssensors.2c00691 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Qiu, Z., Shu, J., Liu, J. and Tang, D. (2018) Dual-Channel Photoelectrochemical Ratiometric Aptasensor with Up-Converting Nanocrystals Using Spatial-Resolved Technique on Homemade 3D Printed Device. Analytical Chemistry, 91, 1260-1268. &gt;https://doi.org/10.1021/acs.analchem.8b05455 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Malvano, F., Albanese, D., Pilloton, R. and Di Matteo, M. (2017) A New Label-Free Impedimetric Aptasensor for Gluten Detection. Food Control, 79, 200-206. &gt;https://doi.org/10.1016/j.foodcont.2017.03.033 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Li, Z., Mohamed, M.A., Vinu Mohan, A.M., Zhu, Z., Sharma, V., Mishra, G.K., et al. (2019) Application of Electrochemical Aptasensors toward Clinical Diagnostics, Food, and Environmental Monitoring: Review. Sensors, 19, Article 5435. &gt;https://doi.org/10.3390/s19245435 
    </mixed-citation>
   </ref>
   <ref id="scirp.137438-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tavakolian-Ardakani, Z., Hosu, O., Cristea, C., Mazloum-Ardakani, M. and Marrazza, G. (2019) Latest Trends in Electrochemical Sensors for Neurotransmitters: A Review. Sensors, 19, Article 2037. &gt;https://doi.org/10.3390/s19092037
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>